Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

RESMED INC Director's Dealing 2011

Jul 18, 2011

30071_dirs_2011-07-18_fba85bdf-6083-4132-8ee4-a3addc60eb6f.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2011-07-14

Reporting Person: PENDARVIS DAVID (Chief Admin Off. & Gen.Counsel)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2011-07-14 ResMed Common Stock M 47500 $21.025 Acquired 73629.887 Direct
2011-07-14 ResMed Common Stock S 47500 $35.00 Disposed 26129.887 Direct
2011-07-14 ResMed Common Stock M 40000 $21.025 Acquired 66129.887 Direct
2011-07-14 ResMed Common Stock S 40000 $32.50 Disposed 26129.887 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2011-07-14 ResMed Common Stock Options $21.025 M 47500 Disposed 2014-11-07 ResMed Common Stock (47500) Direct
2011-07-14 ResMed Common Stock Options $21.025 M 40000 Disposed 2014-11-07 ResMed Common Stock (40000) Direct

Footnotes

F1: This transaction was done in accordance with a 10b5-1 trading plan.

F2: Represents date options first became exercisable.

F3: Includes 404.767 shares of common stock purchased on April 30, 2011, pursuant to ResMed's Employee Stock Purchase Plan.